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Background: Carbapenem-resistance in Acinetobacter baumannii has gradually become a global challenge. To
identify the genes involved in carbapenem resistance in A. baumannii, the transcriptomic responses of the
completely sequenced strain ATCC 17978 selected with 0.5 mg/L (IPM-2 m) and 2 mg/L (IPM-8 m) imipenem
were investigated using RNA-sequencing to identify differences in the gene expression patterns.
Results: A total of 88 and 68 genes were differentially expressed in response to IPM-2 m and IPM-8 m selection,
respectively. Among the expressed genes, 50 genes were highly expressed in IPM-2 m, 30 genes were highly expressed
in IPM-8 m, and 38 genes were expressed common in both strains. Six groups of genes were simultaneously expressed
in IPM-2 m and IPM-8 m mutants. The three gene groups involved in DNA recombination were up-regulated, including
recombinase, transposase and DNA repair, and beta-lactamase OXA-95 and homologous recombination. The remaining
gene groups involved in biofilm formation were down-regulated, including quorum sensing, secretion systems, and the
csu operon. The antibiotic resistance determinants, including RND efflux transporters and multidrug resistance pumps,
were over-expressed in response to IPM-2 m selection, followed by a decrease in response to IPM-8 m selection. Among
the genes over-expressed in both strains, blaOXA-95, previously clustered with the blaOXA-51-like family, showed 14-fold
(IPM-2 m) to 330-fold (IPM-8 m) over-expression. The expression of blaOXA-95 in IPM-2 m and IPM-8 m cells was positively
correlated with the rate of imipenem hydrolysis, as demonstrated through Liquid Chromatography-Mass Spectrometry/
Mass Spectrometry, suggesting that blaOXA-95 plays a critical role in conferring carbapenem resistance. In addition, A.
baumannii shows an inverse relationship between carbapenem resistance and biofilm production.
Conclusion: Gene recombination and blaOXA-95 play critical roles in carbapenem resistance in A. baumannii. Taken
together, the results of the present study provide a foundation for future studies of the network systems associated with
carbapenem resistance.
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In the last decades, A. baumannii has gradually emerged
as an important nosocomial pathogen worldwide, reflect-
ing antimicrobial resistance, tolerance to desiccation and
disinfection and biofilm formation on common abiotic
surfaces in healthcare settings [1]. Carbapenems, primarily
imipenem and meropenem, have been used to treat* Correspondence: d918229@gmail.com
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unless otherwise stated.multidrug-resistant (MDR) A. baumannii infections [1].
However, the increasing incidence of carbapenem-
resistant A. baumannii (CRAB) infections in Taiwan and
many other countries has become of critical concern [2].
Currently, several MDR determinants contribute to the
antimicrobial resistance observed in this microorganism.
The most prevalent MDR determinants in A. baumannii
include genes for efflux pumps, class B β-lactamase
(metallo-beta-lactamase), class C chromosomal β-lacta-
mase AmpC, class D β-lactamase (OXA-type carbapene-
mase), integrons and associated insertion sequence (IS)
elements [1]. Virulence factors associated with resistance,
including biofilm formation, and surface and extracellular
polysaccharides associated with capsule formation haveLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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made in characterizing the determinants of antibiotic
resistance in this organism, few reports have shown the
expression patterns or mechanisms underlying the ac-
quisition or control of these genes.
To characterize the antimicrobial resistance mecha-
nisms underlying MDR in A. baumannii, several ap-
proaches to examine gene expression profiles have been
developed. Proteomics methods using two-dimensional
electrophoresis (2D) and Liquid Chromatography-Mass
Spectrometry/Mass Spectrometry (LC-MS/MS) have
been used to examine changes in A. baumannii protein
expression associated with drug resistance [4-6]. Yun
et al. [4] identified 484 proteins with expression differ-
ences in the clinical MDR strain DU202 subjected to
sub-minimum inhibitory concentration levels of tetra-
cycline and imipenem. Chopra et al. [5] compared the
proteome of the MDR strain BAA-1605 and a reference
strain, identifying nearly 200 proteins with expression
differences between the two strains. Indeed, the proteo-
mics approaches using 2D and LC-MS/MS might pro-
vide large-scale proteomics involved in antibiotic
resistance; however, less than 25% of proteins could be
detected, reflecting the limitations of 2D approaches.
Also, microarray technology has been used to screen
and quantify the expression profiles of antibiotic resist-
ance genes in A. baumannii [7]. However, this approach
has been restricted to the study of previously known
genes, which would not reveal the entire transcriptional
profile of genes expressed upon exposure to antibiotics.
Among the recent techniques used to analyze the
whole RNA profiles of microorganisms are next gener-
ation sequencing (NGS), 454 GS_FLX (Roche), MiSeq or
HiSeq (Illumina Inc.) platforms, and ABI SOLiD (Life
Technology). RNA sequencing using the Illumina system
has been regarded as an extremely informative technique
for the study of transcriptional profiles of microorgan-
isms, as these techniques are sensitive and rapid [8,9].
However, in the last two years, there have only very few
studies using RNA-sequencing technologies in A. bau-
mannii [10-12]. Using transcriptional profiling and func-
tional assays in a mutant strain, Cerqueira et al. [12]
identified a global virulence regulator in A. baumannii
that controls the phenylactic acid catabolic pathway.
Using the same approach, Eijkelkamp et al. [10] also
identified a role for the gene encoding a homolog of the
histone-like nucleoid structuring (H-NS) protein in-
volved in A. baumannii virulence. Currently, there is
only one report concerning the whole transcriptome ana-
lysis of the genes involved in biofilm formation in A. bau-
mannii [11]. Rumbo-Feal et al. [11] identified 1621 genes
over-expressed in biofilms relative to stationary phase cells
and 55 genes expressed only in biofilms. Among the genes
over-expressed in biofilms were those involved in quorumsensing and the CsuAB-A-B-C-D-E chaperone-usher se-
cretion system. Although biofilm formation has been im-
plicated in antibiotic resistance in bacteria [13], the
correlation between antibiotic resistance and biofilm for-
mation in A. baumannii remains poorly understood.
In a previous study [14], we employed genome-wide
analysis to characterize the potential resistance mecha-
nisms in Acinetobacter baumannii ATCC 17978 follow-
ing imipenem exposure. Genome-wide analysis showed
that exposure to 0.5 mg/L imipenem mediated the trans-
position of ISAba1, located upstream of the blaOXA-95
gene, resulting in the overexpression of the blaOXA-95 gene.
Thus, the aim of the present study was to investigate the
carbapenem resistance mechanism in A. baumannii using
the Illumina RNA-sequencing technologies. We therefore
obtained transcriptome profiles from A. baumannii ATCC
17978 and its carbapenem-selected mutants, and these
profiles were compared to identify differences in the gene
expression profiles. The results of the present study will
provide insight into the mechanisms underlying carba-
penem resistance and their association with biofilm forma-
tion in A. baumannii.
Results
Susceptibility testing
Antibiotic-selected mutants were generated from the
ATCC 17978 type strain. The identities of the selected
mutants originated from ATCC 17978 were confirmed
using pulsed-field gel electrophoresis (PFGE). The re-
sults of antibiotic susceptibility testing for these mutants
and the parental strain are shown in Table 1. The refer-
ence strain 17978 was susceptible to all antibiotics
tested. The MICs to meropenem and imipenem were in-
creased more than four-fold in response to IPM-2 m
and IPM-8 m selection at concentrations of 0.5 and
2 mg/L imipenem. In addition, the MICs of the
imipenem-selected mutants to the other antibiotics were
similar compared with the ATCC 17978 strain.
Determination of the transcriptomes of imipenem-
selected mutants and the parental strains
The total RNA fractions purified from IPM-2 m, IPM-8 m
and ATCC17978 strains were analyzed to determine the
respective gene expression levels and identify differentially
expressed genes. Three libraries were constructed and
subjected to paired-end sequencing using HiSeq 2000
(Illumina). The reads were aligned against the chromo-
somes and plasmids of A. baumannii ATCC 17978. A
total of 11,995,382, 11,933,930, and 12,036,770 paired
reads with lengths of 90 bases × 2 were obtained for IPM-
2 m, IPM-8 m, and ATCC 17978, respectively. Approxi-
mately 99% of the transcribed genes aligned in the A.
baumannii ATCC 17978 genome database (NC_009085.1)
were recorded.
Table 1 Susceptibility of A. baumannii ATCC 17978
selected with imipenem




Imipenema ≦0.25 1 ≧16
Meropenema ≦0.25 2 ≧16
Ceftazidime 4 4 4
Cefepime 2 2 2
Amikacin ≦2 ≦2 ≦2
Gentamicin ≦1 ≦1 ≦1
Ciprofloxacin ≦0.25 ≦0.25 ≦0.25
Levofloxacin 0.25 0.25 0.25
Ampicillin/subactam ≦2 4 4
Trimethoprim/Sulfamethoxazole 160 160 160
aA more than fourfold induction is indicated in boldface.
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quencing, were validated through the RT-qPCR analysis
of a subset of differentially expressed genes as shown in
Figure 1. A good correlation was observed between the
RT-qPCR data and the results obtained from the tran-
scriptome analysis of IPM-2 m (R2 = 0.8359) and IPM-
8 m (R2 = 0.9428).The gene expression profiles of imipenem-selected cells
The expression patterns of IPM-2 m vs. ATCC 17978
cells and IPM-8 m vs. ATCC 17978 cells were compared
to identify differentially expressed transcripts. The up-
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Figure 1 Validation of the transcriptome results. The transcriptomic res
qualitative RT-PCR (RT-qPCR) analysis. The level of differential expression
sequencing (Y-axis) and RT-qPCR analysis (X-axis). The level of differential
given as Log2-values. R
2, the coefficient of determination.differences with p values below 0.05. Figure 2 shows the
differentially expressed genes in IPM-2 m and IPM-8 m
relative to the ATCC 17978 strain. A total of 88 and 68
genes were differentially expressed in IPM-2 m and
IPM-8 m, respectively. Among these, 50 genes were
highly expressed in IPM-2 m, 30 genes were highly
expressed in IPM-8 m, and 38 genes were expressed
common in both strains.
Figure 3 summarizes the transcriptional responses of
ATCC 17978 upon selection with 0.5 mg/L (IPM-2 m)
and 2 mg/L (IPM-8 m) imipenem. The differentially
expressed genes were classified into functional groups
based on COG category or KEGG pathways as shown in
Table 2. Six groups of genes were identified: three
groups were up-regulated, including recombinase, trans-
posase and DNA repair, and beta-lactamase OXA-95
and homologous recombination, and three groups were
down-regulated, including quorum sensing, secretion
systems, and the csu operon, and these gene groups
were simultaneously expressed in IPM-2 m and IPM-
8 m mutants. In addition, three groups of genes, including
the RND efflux pump, lipase, the multidrug efflux pump
and aminobenzoate degradation, were up-regulated in
IPM-2 m, and two groups of genes, including fatty acid
metabolism and CoA synthase, hydratase and lyase, were
down-regulated only in IPM-8 m. The genes with the
highest overexpression were located in recombinase and
transposase and DNA repair groups in IPM-2 m and
IPM-8 m cells, highlighting the potential importance of
these genes in carbapenem resistance in A. baumannii.
Moreover, a rapid increase in blaOXA-95 (A1S_1517) ex-
pression from 14-fold (IPM-2 m) to 330-fold (IPM-8 m)
suggests that blaOXA-95 might participate in carbapenem
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Figure 2 The differentially expressed genes in IMP-2 m and IMP-8 m relative to the ATCC 17978 wild-type strain. A Venn Diagram
showing the relationship of differentially expressed genes between IPM-2 m and IPM-8 m. The heatmaps shown below demonstrate the
expression patterns of the 50 genes unique to IPM-2 m, the 30 genes unique to IPM-8 m, and the 38 genes common to both strains.
Figure 3 Overview of the transcriptional difference between the IPM strains and the ATCC 17978 wild-type strain. Comparative
transcriptomics are displayed as differential expression (log2 transformed fold change) in (A) IPM-2 m and (B) IPM-8 m relative to ATCC
17978. The dots indicate the differential expression of all open reading frames, sorted on the x-axis according to the locus tag. Genes with
p-values < 0.05 are considered differentially expressed. The red dots indicate up-regulated genes, whereas the green dots indicate
down-regulated genes. Some differentially expressed genes are indicated in the literature and KEGG pathway information.
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Table 2 Functional groups of differentially expressed genes between mutant strains and ATCC 17978
Locus
tag
log2 (fold change) log2 (fold change) Protein name
in IPM-2 m in IPM-8 m
Recombinase
A1S_0015 7.74 8.92 Hypothetical protein A1S_0015
A1S_0016 7.90 8.30 Site-specific tyrosine recombinase
Fatty acid metabolism
A1S_0106 −0.23 −3.05 Putative enoyl-CoA hydratase/isomerase
A1S_0107 −0.27 −3.08 Putative enoyl-CoA hydratase/isomerase family protein
A1S_0109 −3.62 −6.03 Homoserine lactone synthase
Quorum sensing
A1S_0112 −1.86 −4.76 Acyl-CoA synthetase/AMP-acid ligases II
A1S_0115 −2.47 −5.27 Amino acid adenylation
A1S_0116 −2.97 −6.01 RND superfamily transporter
A1S_0117 −1.38 −2.92 Hypothetical proteinA1S_0117
A1S_0118 −2.01 −4.06 Hypothetical protein A1S_0118
Transposase
A1S_0209 4.76 4.82 Transposase
A1S_0210 3.17 2.89 Transposase
RND eflux transporter
A1S_0535 4.19 0.28 RND efflux transporter
A1S_0536 4.93 0.86 Macrolide transport protein
A1S_0537 4.74 0.83 RND efflux transporter
A1S_0538 4.48 0.39 RND efflux transporter
Transposase and DNA repair
A1S_0623 8.34 7.98 DNA mismatch repair enzyme
A1S_0626 6.04 5.06 Hypothetical protein A1S_0626
A1S_0627 6.20 6.38 Hypothetical protein A1S_0627
A1S_0628 6.93 6.67 Putative transposase
A1S_0630 4.72 5.14 Hypothetical protein A1S_0630
A1S_0631 6.12 5.52 Hypothetical protein A1S_0631
A1S_0632 7.45 7.19 DNA primase
A1S_0633 6.13 5.74 Hypothetical protein A1S_0633
A1S_0634 5.17 4.93 Hypothetical protein A1S_0634
A1S_0637 6.21 6.52 DNA-directed DNA polymerase
A1S_0638 7.37 7.45 Hypothetical protein A1S_0638
A1S_0640 6.91 6.41 Hypothetical protein A1S_0640
A1S_0646 7.36 7.00 IcmB protein
A1S_0649 8.52 8.43 Putative phage primase
A1S_0650 7.02 6.46 Conjugal transfer protein
A1S_0651 6.67 6.32 TraB protein
A1S_0652 8.02 7.83 Putative ferrous iron transport protein A
A1S_0661 6.22 5.70 Phage integrase family protein
A1S_0665 6.79 6.34 Conjugal transfer protein TrbJ
A1S_0666 7.50 7.16 TrbL/VirB6 plasmid conjugal transfer protein
A1S_0671 7.89 6.92 Protein tyrosine phosphatase
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Table 2 Functional groups of differentially expressed genes between mutant strains and ATCC 17978 (Continued)
CoA synthase/hydratase/lyase
A1S_1109 −0.77 −3.66 Feruloyl-CoA synthase
A1S_1110 −0.48 −3.48 Hydroxybenzaldehyde dehydrogenase
A1S_1111 −0.41 −4.66 P-hydroxycinnamoyl CoA hydratase/lyase
A1S_1112 −0.53 −3.19 Putative 3-hydroxyphenylpropionic transporter MhpT
Lipase
A1S_1121 4.63 2.24 Lipase/esterase
A1S_1122 3.36 0.67 Putative short-chain dehydrogenase
A1S_1123 2.77 0.59 Putative flavin-binding monooxygenase
Bacterial secretion system, OOP family
A1S_1272 −3.30 −3.31 Putative transcriptional regulator
A1S_1296 −3.49 −3.45 Hypothetical protein A1S_1296
A1S_129 −2.42 −2.77 Hypothetical protein A1S_1297
A1S_1305 −2.59 −2.36 Putative outer membrane lipoprotein
A1S_1307 −3.03 −2.35 Putative ClpA/B-type chaperone
A1S_1308 −2.93 −3.06 Hypothetical protein A1S_1308
A1S_1309 −3.75 −2.86 Hypothetical protein A1S_1309
A1S_1310 −2.91 −2.58 Hypothetical protein A1S_1310
Homologous recombination; Biosynthesis of secondary metabolites
A1S_1511 −0.58 3.30 Biotin synthase
A1S_1512 0.96 5.28 Putative ferredoxin
A1S_1513 0.27 3.71 Hypothetical protein A1S_1513
A1S_1514 1.61 4.81 Holliday junction nuclease
A1S_1515 0.24 3.04 Hypothetical protein A1S_1515
A1S_1516 2.80 6.15 Putative antibiotic resistance
A1S_1517 3.79 8.36 Beta-lactamase OXA-95
Multidrug efflux pump; Aminobenzoate degradation
A1S_1750 2.52 0.26 AdeB
A1S_1857 3.29 0.51 Vanillate O-demethylase oxidoreductase
A1S_1858 3.32 0.36 Short-chain dehydrogenase/reductase SDR
A1S_1860 2.74 −2.86 Ring hydroxylating dioxygenase Rieske (2Fe-2S) protein
A1S_1861 3.70 0.53 Benzoate dioxygenase large subunit
A1S_1863 3.84 −1.41 Hypothetical protein A1S_1863
A1S_1864 4.73 −1.58 Acyl-CoA dehydrogenase-like protein
A1S_1865 4.25 −2.30 Glu-tRNA amidotransferase
A1S_1867 3.71 0.03 Major facilitator transporter
Csu Operon
A1S_2213 −2.06 −3.63 CsuE
A1S_2214 −2.40 −3.86 CsuD
A1S_2215 −3.14 −4.57 CsuC
A1S_2216 −2.73 −4.45 CsuB
A1S_2217 −2.53 −4.18 CsuA
A1S_2218 −3.89 −5.88 CsuA/B
Chang et al. BMC Genomics 2014, 15:815 Page 6 of 13
http://www.biomedcentral.com/1471-2164/15/815
Table 2 Functional groups of differentially expressed genes between mutant strains and ATCC 17978 (Continued)
ABC transporters
A1S_2531 3.20 0.22 Sulfate transport protein
A1S_2533 3.21 1.45 Putative esterase
A1S_2534 3.34 2.02 Sulfate transport protein
Others
A1S_0032 7.09 0.49 Putative signal peptide
A1S_0033 5.60 1.73 Putative signal peptide
A1S_0058 −2.62 −1.47 Glycosyltransferase
A1S_0087 −3.76 −4.52 Short-chain dehydrogenase/reductase SDR
A1S_0097 −2.79 −0.41 Hypothetical protein A1S_0097
A1S_0158 2.91 −0.15 Hypothetical protein A1S_0158
A1S_0161 −2.53 −2.86 MFS family transporter
A1S_0172 −2.10 −2.92 Hypothetical protein A1S_0172
A1S_0511 3.17 1.25 Hypothetical protein A1S_0511
A1S_0548 −2.94 −1.92 TetR family transcriptional regulator
A1S_0721 2.62 1.15 Glutaryl-CoA dehydrogenase
A1S_0835 2.91 0.52 Outer-membrane lipoprotein precursor
A1S_1224 2.03 3.81 Transposase
A1S_1390 −3.20 −0.97 Hypothetical protein A1S_1390
A1S_1441 2.91 −0.31 Putative signal peptide
A1S_1879 −2.81 −1.76 Hypothetical protein A1S_1879
A1S_1950 −1.32 −2.85 Putative universal stress protein
A1S_2157 5.72 1.02 Putative signal peptide
A1S_2158 2.78 0.36 Putative monooxygenase
A1S_2225 −1.04 −3.21 Hypothetical protein A1S_2225
A1S_2259 2.84 0.15 Putative signal peptide
A1S_2325 3.00 1.40 Putative outer membrane protein
A1S_2434 2.65 1.60 Putative signal peptide
A1S_2455 3.89 0.89 Putative signal peptide
A1S_2456 3.38 1.59 LysR family transcriptional regulator
A1S_2463 2.16 2.87 Putative ribosomal large subunit pseudouridine synthase A(RluA-like)
A1S_2487 −3.93 −4.93 Hypothetical protein A1S_2487
A1S_2511 −1.62 −2.74 Phenylacetic acid degradation-related protein
A1S_2554 5.96 6.16 Putative transposase
A1S_2699 −2.51 −2.80 Putative transcriptional regulator
A1S_2729 3.67 −0.15 Outer-membrane lipoproteins carrier protein
A1S_2885 6.80 0.78 Putative signal peptide
A1S_2889 6.72 1.25 Putative signal peptide
A1S_3034 2.80 0.44 Hypothetical protein A1S_3034
A1S_3085 −5.00 −2.34 Putative flavohemoprotein
A1S_3086 −3.09 −1.21 Hypothetical protein A1S_3086
A1S_3100 3.18 0.18 Putative toluene tolerance protein (Ttg2D)
A1S_3139 3.16 0.03 Putative signal peptide
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Table 2 Functional groups of differentially expressed genes between mutant strains and ATCC 17978 (Continued)
A1S_3273 −3.03 −1.79 Putative peptide signal
A1S_3363 −1.98 −2.86 Membrane metalloendopeptidases proteins
A1S_3415 0.09 −2.84 Maleylacetoacetate isomerase
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homoserine lactone synthase (A1S_0109), 17- (IPM-2 m) to
70-fold (IPM-8 m) reduction; quorum sensing group
(A1S_0112, 0115, 0116,0117 and 0118), average 5- to 20-
fold reduction; CoA synthase, hydratase and lyase group
(A1S_1109, 1110 and 1111 ), 1.5- to 17-fold reduction; and
the csu operon (A1S_2213 to A1S_2218), 8- to 25-fold re-
duction. Notably, many up-regulated genes were only re-
stricted to IPM-2 m. Among 50 up-regulated genes, ten
genes annotated as putative signal peptides were highly
expressed in IPM-2 m cells, followed by a decrease in ex-
pression in IPM-8 m cells.
Table 3 shows the comparative results of differentially
expressed genes in imipenem-selected mutants and
biofilm-associated ATCC 17978, as previously described
[11]. Many biofilm-associated genes, including quorum
sensing-associated genes (A1S_0109, A1S_0112 and
A1S_0115) and the CsuAB-A-B-C-D-E chaperone-usher
secretion system (A1S_2214, A1S_2215 and A1S_2218),
were inversely expressed in imipenem-selected mutants.
However, four genes encoding the RND efflux trans-
porter, sulfate transport protein and putative signal pep-
tides, were overexpressed in both strains, indicating thatTable 3 Comparison of differentially expressed genes betwee
biofilm-associated ATCC 17978 cells as decribed by Rumbo-F
Locus tag Log2 (fold change) in
IPM-2 m




Inverse expressed between imipenem-resistant mutants and biofilm-as
NameA1S_0087 −3.76 −4.52 1.36
A1S_0109 −3.62 −6.03 5.91
A1S_0112 −1.86 −4.76 6.23
A1S_0115 −2.47 −5.27 7.24
A1S_0116 −2.97 −6.01 5.81
A1S_0117 −1.38 −2.92 4.58
A1S_0118 −2.01 −4.06 3.21
A1S_2214 −2.40 −3.86 7.49
A1S_2215 −3.14 −4.57 7.65
A1S_2218 −3.89 −5.88 7.36
Overexpressed both in imipenem-resistant mutants and biofilm-associa
A1S_0538 4.48 0.39 2.72
A1S_2534 3.34 2.02 4.40
A1S_0032 7.09 0.49 5.01
A1S_2889 6.72 1.25 5.54those genes might participate in pathways overlapping
carbapenem resistance and biofilm formation.Measurement of carbapenemase hydrolysis
To examine carbapenemase hydrolysis in ATCC 17978,
IPM-2 m and IPM-8 m cells, LC-MS/MS was performed,
and the results are shown in Figure 4. The rate of imipe-
nem hydrolysis was calculated by dividing the imipenem
area after the incubation procedure by A. baumannii
ATCC 17978 area. Compared with IPM-2 m, the rate of
imipenem hydrolysis in IPM-8 m showed a 430-fold
increase.Quantitative analysis of biofilm formation
To clarify the association between biofilm formation and
carbapenem resistance in A. baumannii, biofilm forma-
tion in ATCC 17978 and imipenem-selected mutants
was quantitative analyzed as shown in Figure 5. A sig-
nificant decrease in biofilm formation (p < 0.001) was
observed in IPM-2 m and IPM-8 m cells, indicating an
inverse relationship between carbapenem resistance and
biofilm production in A. baumannii ATCC 17978.n imipenem-selected mutants (this study) and
eal et al. (12)
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Figure 4 LC-MS/MS chromatogram of imipenem under co-incubating with A. baumannii ATCC 17978, IPM-2 m and IPM-8 m cells.
Control, imipenem standard solution.
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In the present study, we successfully constructed an
antibiotic-induction platform to observe dynamic tran-
scriptome changes upon carbapenem selection. A. bau-
mannii ATCC 17978 was selected as the study material
based on three advantages. First, the complete genome
of this organism has been sequenced since 2007 [15].
Second, the MICs for most commonly used antibiotics,
such as the 3rd cephalosporins, aminoglycosides, carba-
penems and fluoroquinolones, are still susceptible; thus,Figure 5 Quantification of biofilm formation in A. baumannii
strains on plastic surface. To determine total cell mass the OD600
was measured after the cultures were briefly sonicated to resuspend
most of the cells. The OD580 was measured after the stained tubes
were incubated with ethanol-acetone. The error bar show the S.D.
***,p < 0.0001 using Student’s t-test comparing mutant and wild-type
strains.A. baumannii ATCC 17978 would be a model candidate
for antibiotic selection experiments. Third, the gradual
increase of MIC observed only for carbapenem suggests
that the carbapenem-specific resistance mechanism
could be studied using an imipenem-selected platform.
In our previous study using genome-wide analysis
[14], we demonstrated that imipenem exposure at a con-
centration of 0.5 mg/L only mediated the transposition
of ISAba1 upstream of the blaOXA-95 gene. None of the
other genes in imipenem-selected mutants were modi-
fied, rearranged or acquired by horizontal-gene transfer
upon imipenem exposure compared to their parental
strains. To continue the previous study, herein, we ex-
amined the transcriptional profiles of A. baumannii
ATCC 17978 upon selection with imipenem gradient.
Despite all the gene expression analysis were done with
strains cultured in the absence of antibiotics, the MICs
to imipenem in IPM-2 m and IPM-8 m remained
unchangeable, indicating that these mutants were stable.
Besides, the MICs observed in response to imipenem
selection in IPM-2 m and IPM-8 m cells were 1 and
>16 mg/L, respectively, reflecting imipenem-susceptibility
and imipenem-resistance according to the CLSI guidelines
[16]. Thus, the results of the present study showed the
dynamic changes in the transcriptome profiles, from
imipenem-susceptible to imipenem-resistance during the
selection period, representing the first study to demonstrate
the potential mechanisms underlying carbapenem resist-
ance in A. baumannii ATCC 17978.
Thus, several novel findings have been revealed in the
present study. First, many of the highly expressed genes
encoding proteins for recombinase, transposase, and
DNA repair were simultaneously observed in IPM-2 m
and IPM-8 m cells. This result suggests that genome
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ring carbapenem resistance, consistent with the conclu-
sions of several reports using genetic analysis [17,18].
Second, the overexpression of several genes involved in
RND efflux transporters and fatty acid metabolism were
observed in IPM-2 m cells, and this expression was
reduced in IPM-8 m cells. Despite several reports em-
phasizing the major role of efflux pumps in the develop-
ment of antimicrobial resistance in Acinetobacter spp.
[19,20], the results obtained herein are consistent with
those of previous reports showing that efflux pumps,
particularly RND-type transporters, play an important
role in the initial exposure to imipenem and are subse-
quently down-regulated during carbapenem resistance.
In other words, efflux pumps alone may be not sufficient
to provide protection against a high concentration of
carbapenem. Third, several genes involved in quorum
sensing and the CsuAB-A-B-C-D-E chaperone-usher se-
cretion system are down-regulated upon selection with
imipenem. The disruption of these genes has been asso-
ciated with a decrease in biofilm formation [11]. The re-
sults of other studies concerning carbapenem resistance
and biofilm formation showed reduced biofilm formation
in meropenem (MEM)-resistant A. baumannii isolates
compared with MEM-susceptible strains [21], consistent
with the results obtained in either biofilm-associated gene
expression or the phenotypic determination of biofilm
production in A. baumannii strains. To date, the ability of
A. baumannii to form biofilms that adhere to and persist
on a broad range of surfaces might be key to revealing the
pathogenic mechanisms of this microorganism [22].
Therefore, we hypothesize that carbapenem resistance
might reduce virulence through the reduction of biofilm
production in some A. baumannii strains.
The rapid adaption to the environment might emphasize
the ability of microorganisms to live under external stress.
Dynamic changes in genome architecture and gene expres-
sion are required for organisms to survive in their environ-
ment. Dynamic changes in the gene expression of A.
baumannii have been observed in biofilm compared with
planktonic cells using whole transcriptome analysis [11].
Also, the transcriptional responses of A. baumannii to
environmental stress have been reported [23,24]. For ex-
ample, several siderophore biosynthesis genes were up-
regulated in response to iron starvation and therefore are
likely to be important for the survival of A. baumannii in
iron-limited environments. In addition, various type IV pi-
lus genes were also down-regulated [23]. In the present
study, dynamic changes in the transcriptional responses to
carbapenem concentrations ranging from 0.5 mg/L (mild
stress) to 2 mg/L (stringent stress) have also been observed.
Herein, we propose a “bacterial energy conversion hypoth-
esis” to describe the dynamic changes in the transcriptome
upon carbapenem stress in A. baumannii ATCC 17978.First, the net energy required for metabolism is constant
throughout the life of the cell. For rapid adaption and sur-
vival upon environmental stress, many genes in cells are
monitored and up-regulated to overcome the external
stress, and much energy is required for the expression of
these genes. However, several genes that are not required
for survival are down-regulated to save energy. In the
present study, several genes, including the RND efflux
transporter, lipase, recombination-associated proteins, and
blaOXA-95, are up-regulated in A. baumannii upon expos-
ure to mild carbapenem stress. Several biofilm-associated
genes, including quorum sensing, protein secretion system
and the CsuAB-A-B-C-D-E chaperone-usher secretion sys-
tem, which could be not required against for imipenem
pressure, have been down-regulated. To adapt to a more
stringent environment, the overexpression of target sur-
vival genes, e.g. blaOXA-95, is needed, resulting in the con-
sumption of most of the energy in the cell. Thus, some of
the genes up-regulated during mild stress, e.g. efflux
pumps, are down-regulated so as to transform excess en-
ergy and maintain cell viability despite efflux pumps play
important roles in the resistance to antibiotics [25]. The
bacterial energy conversion hypothesis requires more evi-
dences to verify, however, in the present study, the results
of transcriptomic analysis and LC-MS/MS demonstrated
that blaOXA-95 might play a critical role in survival upon
exposure to stringent carbapenem stress in A. baumannii
ATCC 17978. Moreover, the transposition of ISAba1 up-
stream of the blaOXA-95 gene is observed upon exposure to
mild carbapenem stress, suggesting that the upstream sig-
naling pathway linking external stress and ISAba1 trans-
position may be a critical mechanism for carbapenem
resistance in A. baumannii ATCC 17978.
Conclusions
This study defined the global transcriptional response of
A. baumannii to imipenem exposure. The up-regulation
of recombination-associated genes and blaOXA-95 was
the predominant feature of this transcriptional response.
Several genes involved in biofilm formation, such as
quorum sensing, protein secretion system and the
CsuAB-A-B-C-D-E chaperone-usher secretion system,
were down-regulated upon imipenem selection, resulting
in the reduction of biofilm production. Overall, the re-
sults indicated that A. baumannii adapts to an environ-
ment with carbapenem availability.
Methods
Bacterial strains
A. baumannii ATCC 17978 was used as a parental strain.
The carbapenem-selected mutants were generated from
the parental strain using a previously described method
[26]. The selected strains exposed to 0.5 and 2 mg/L
imipenem were collected during the induction period and
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patterns in the selected mutants and the parental strain
were determined using PFGE, as previously described [27].
Antimicrobial susceptibility
The susceptibility of the Acinetobacter mutants and the
parental strain to antimicrobial agents was determined
using a microdilution method in accordance with the
guidelines of the Clinical and Laboratory Standards
Institute [16]. The agents tested included ampicillin/sul-
bactam, ceftazidime, cefepime, amikacin, gentamicin,
ciprofloxacin, levofloxacin, trimethoprim/sulfamethoxa-
zole, imipenem and meropenem. Escherichia coli strain
ATCC 25922 and Pseudomonas aeruginosa strain ATCC
27853 were used as reference controls for the suscepti-
bility testing. A four-fold or greater induction in the
minimum inhibitory concentration (MIC) values after
exposure to imipenem was considered significantly dif-
ferent from the control.
RNA isolation and library preparation for transcriptome
sequencing
A. baumannii cultures were grown to log phase (OD600
1.00) in Muller Hinton broth with shaking at 37°C before
RNA extraction. Total RNA was isolated from cells using
the PureLink™ Micro-to-Midi Total RNA Purification Sys-
tem (Invitrogen, Life Technologies, Carlsbad, CA, USA)
according to the manufacturer’s instructions. The RNA
quantity and quality were assessed using a BIOANALY-
ZER 2100 (Agilent Technologies Inc., Germany), followed
by RNA-Seq. The RNA integrity number (RIN) of total
RNA should be greater than 8.0, and rRNA ratio (23S/
16S) should be greater than 1.2.
The RNA-sequencing library was prepared as previously
described [28]. The constructed sequencing libraries were
sequenced using the Illumina HiSeq 2000 platform at
Beijing Genome Institute (BGI, Shenzhen, China).
Analysis of the RNA-Seq data
The sequenced libraries were mapped against predicted
transcripts from the Acinetobacter baumannii ATCC
17978 genome using TopHat v2.0.4 [29]. The transcript
abundance (FPKM, Fragments Per Kilobase of exon per
Million fragments mapped) and significant changes in
transcript expression were estimated using Cufflinks
v2.0.2 [30,31]. Transcripts with p-values less than 0.05,
determined using CuffDiff [31], were considered differ-
entially expressed between mutant and wild-type strains.
The transcripts were annotated with Cluster of Ortholo-
gous Groups (COG) and protein functions according to
their locus tags [32]. The functional groups comprising
differentially expressed transcripts were manually cu-
retted based on COG annotation, Kyoto Encyclopedia of
Genes and Genomes (KEGG) [33], and studies cited inthe corresponding main text. Raw sequences were de-
posited at the NCBI sequence Read Archive under the
Bioproject accession number PRJNA244702.
Quantitative biofilm formation
Biofilm formation on polystyrene was assessed through
the crystal violet staining of cells cultured in LB broth as
previously described [34]. Each experiment was per-
formed in triplicate and repeated three times.
Reverse transcriptase-quantitative PCR (RT-qPCR)
Gene expression was analyzed using a previously de-
scribed method [26]. Briefly, total RNA was isolated
from 1 × 109 A. baumannii cells. After DNase treatment
of the RNA samples and cDNA synthesis, RT-qPCR was
performed as previously described [26]. The template
cDNA was diluted 1:100, and 2.5 μl was added to SYBR
green PCR master mix (Biogenesis Technologies, Inc.,
Taiwan) for each reaction. An Eco Real-Time PCR
System (Illumina) was used for analysis. Internal forward
and reverse primers for each gene were designed using the
DesignStudio web-based tool (Illumina), as described in
supporting information (Additional file 1: Table S1). The
experiments were repeated in triplicate independent experi-
ments. Normalization to the 16S ribosomal gene facilitated
the calculation of the fold-changes using the threshold cycle
(CT) method [35].
Detection of carbapenemase hydrolysis using LC-MS/MS
Each strain was analyzed using LC-MS/MS to detect imi-
penem hydrolysis as previously described [36]. Briefly, the
strains were cultured overnight on Mueller-Hinton agar.
The bacteria were dissolved in normal saline solution and
adjusted to OD600 = 2.0. A 1-mL volume of this suspen-
sion was incubated with 5 μg/mL of imipenem for 1 h at
37°C with smooth agitation. The suspensions were subse-
quently centrifuged at 12,000 g for 5 min, and 300 μL of
supernatant was mixed with 700 μL of methanol. After
centrifugation at 12,000 g for 5 min, 200 μL of super-
natant was mixed with 800 μL of water. The abundance of
imipenem was measured through LC-MS/MS using the
Thermo Accela LC system (Waltham, MA) coupled to a
TSQ Quantum tandem triple-quadrupole mass spectrom-
eter. Briefly, the chromatography step was performed
using a fused-core Poroshell C18 column (Agilent) and
eluted with mobile phase A (0.1% formic acid in water)
and B (0.1% formic acid in methanol). Chromatographic
separation was achieved through gradient elution at a flow
rate of 0.32 mL/min. The injection volume was 10 μL.
The retention time for imipenem was 0.88 min. Ionization
was achieved using electrospray in positive ionization
mode (ESI+). The multiple-reaction-monitored parameters
were optimized through post-column infusion of the stock
solution (1 μg/mL) using Quantum TuneMaster software
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and collision energy (27 V) for imipenem transition (m/z
300.1 > 142.2).
Statistical analysis
The differences in biofilm production between imipenem-
selected mutants and the parental strains were analyzed
using Student’s t-test, as appropriate. The differences be-
tween the two groups of isolates were considered signifi-
cant at the p < 0.05 level. The data entry and analyses
were performed using the Statistical Package for the Social
Sciences (SPSS) software version 15.0 (SPSS Inc., Chicago,
IL, USA).
Additional file
Additional file 1: Table S1. Oligonucleotides used in RT-qPCR.
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